The biofluid-based biomarker Glial Fibrillary Acidic Protein (GFAP) and its breakdown products (GFAP-BDPs) may be useful for diagnosing neurological diseases such as PD [85]. The gene discussed is GFAP; the disease is Parkinson disease.